Works matching AU Lee, Keun-Wook

Results: 141
    1

    Pairwise analysis of plasma cell-free DNA before and after palliative second-line paclitaxel plus ramucirumab treatment in patients with metastatic gastric cancer.

    Published in:
    Gastric Cancer, 2025, v. 28, n. 4, p. 620, doi. 10.1007/s10120-025-01604-y
    By:
    • Kim, Ji-Won;
    • Kyung, Dong Soo;
    • Ko, Won Yeong;
    • Kim, Hwang-Phill;
    • Hwang, Sung-Hyun;
    • Kim, Kui-Jin;
    • Lee, Ju Hyun;
    • Seo, Jeongmin;
    • Kang, Minsu;
    • Jung, Eun Hee;
    • Suh, Koung Jin;
    • Kim, Se Hyun;
    • Kim, Jin Won;
    • Kim, Yu Jung;
    • Kim, Jee Hyun;
    • Lee, Keun-Wook
    Publication type:
    Article
    2

    Garsorasib, a KRAS G12C inhibitor, with or without cetuximab, an EGFR antibody, in colorectal cancer cohorts of a phase II trial in advanced solid tumors with KRAS G12C mutation.

    Published in:
    Signal Transduction & Targeted Therapy, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41392-025-02274-z
    By:
    • Ruan, Dan-Yun;
    • Wu, Hao-Xiang;
    • Xu, Ye;
    • Munster, Pamela N.;
    • Deng, Yanhong;
    • Richardson, Gary;
    • Yan, Dong;
    • Lee, Myung-Ah;
    • Lee, Keun-Wook;
    • Pan, Hongming;
    • Hager, Steven;
    • Li, Xingya;
    • Wei, Shaozhong;
    • Hou, Xinfang;
    • Underhill, Craig;
    • Millward, Michael;
    • Nordman, Ina;
    • Zhang, Jingdong;
    • Shan, Jianzhen;
    • Han, Guohong
    Publication type:
    Article
    3
    4
    5
    6

    Pembrolizumab or pembrolizumab plus chemotherapy versus standard of care chemotherapy in patients with advanced gastric or gastroesophageal junction adenocarcinoma: Asian subgroup analysis of KEYNOTE-062.

    Published in:
    Japanese Journal of Clinical Oncology, 2023, v. 53, n. 3, p. 221, doi. 10.1093/jjco/hyac188
    By:
    • Satake, Hironaga;
    • Lee, Keun-Wook;
    • Chung, Hyun Cheol;
    • Lee, Jeeyun;
    • Yamaguchi, Kensei;
    • Chen, Jen-Shi;
    • Yoshikawa, Takaki;
    • Amagai, Kenji;
    • Yeh, Kun-Huei;
    • Goto, Masahiro;
    • Chao, Yee;
    • Lam, Ka-On;
    • Han, Shi Rong;
    • Shiratori, Shinichi;
    • Shah, Sukrut;
    • Shitara, Kohei
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13

    Cetuximab resistance induced by hepatocyte growth factor is overcome by MET inhibition in KRAS, NRAS, and BRAF wild-type colorectal cancers.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 11, p. 2995, doi. 10.1007/s00432-021-03872-4
    By:
    • Kim, Sang-A;
    • Park, Hyejoo;
    • Kim, Kui-Jin;
    • Kim, Ji-Won;
    • Sung, Ji Hea;
    • Nam, Milang;
    • Lee, Ju Hyun;
    • Jung, Eun Hee;
    • Suh, Koung Jin;
    • Lee, Ji Yun;
    • Kim, Se Hyun;
    • Lee, Jeong-Ok;
    • Kim, Jin Won;
    • Kim, Yu Jung;
    • Kim, Jee Hyun;
    • Bang, Soo-Mee;
    • Lee, Jong Seok;
    • Lee, Keun-Wook
    Publication type:
    Article
    14
    15

    Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18–12.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 12, p. 3359, doi. 10.1007/s00432-020-03316-5
    By:
    • Park, Ji Hyun;
    • Chun, Sang Hoon;
    • Lee, Yun-Gyoo;
    • Chang, Hyun;
    • Lee, Keun-Wook;
    • Kim, Hye Ryun;
    • Shin, Seong Hoon;
    • An, Ho Jung;
    • Lee, Kyoung Eun;
    • Hwang, In Gyu;
    • Ahn, Myung-Ju;
    • Kim, Sung-Bae;
    • Keam, Bhumsuk
    Publication type:
    Article
    16
    17
    18
    19
    20
    21

    Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG).

    Published in:
    Gastric Cancer, 2018, v. 21, n. 5, p. 819, doi. 10.1007/s10120-018-0806-1
    By:
    • Jung, Minkyu;
    • Ryu, Min-Hee;
    • Oh, Do Youn;
    • Kang, Myounghee;
    • Zang, Dae Young;
    • Hwang, In Gyu;
    • Lee, Keun-Wook;
    • Kim, Ki Hyang;
    • Shim, Byoung Yong;
    • Song, Eun Kee;
    • Sym, Sun Jin;
    • Han, Hye Sook;
    • Park, Young Lee;
    • Kim, Jin Soo;
    • Lee, Hyun Woo;
    • Lee, Moon Hee;
    • Koo, Dong-Hoe;
    • Song, Hong Suk;
    • Lee, Namsu;
    • Yang, Sung Hyun
    Publication type:
    Article
    22
    23
    24
    25
    26

    Amphiregulin can predict treatment resistance to palliative first-line cetuximab plus FOLFIRI chemotherapy in patients with RAS wild-type metastatic colorectal cancer.

    Published in:
    Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-03197-9
    By:
    • Kim, Sang-A;
    • Park, Hyejoo;
    • Kim, Kui-Jin;
    • Kim, Ji-Won;
    • Sung, Ji Hea;
    • Nam, Milang;
    • Lee, Ju Hyun;
    • Jung, Eun Hee;
    • Suh, Koung Jin;
    • Lee, Ji Yun;
    • Kim, Se Hyun;
    • Lee, Jeong-Ok;
    • Kim, Jin Won;
    • Kim, Yu Jung;
    • Kim, Jee Hyun;
    • Bang, Soo-Mee;
    • Lee, Jong Seok;
    • Lee, Keun-Wook
    Publication type:
    Article
    27
    28
    29
    30
    31
    32
    33
    34

    INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gastro-Intestinal Trials Group (AGITG).

    Published in:
    BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10642-7
    By:
    • Lam, Lyn Ley;
    • Pavlakis, Nick;
    • Shitara, Kohei;
    • Sjoquist, Katrin M.;
    • Martin, Andrew J.;
    • Yip, Sonia;
    • Kang, Yoon-Koo;
    • Bang, Yung-Jue;
    • Chen, Li-Tzong;
    • Moehler, Markus;
    • Bekaii-Saab, Tanios;
    • Alcindor, Thierry;
    • O'Callaghan, Christopher J.;
    • Tebbutt, Niall C.;
    • Hague, Wendy;
    • Chan, Howard;
    • Rha, Sun Young;
    • Lee, Keun-Wook;
    • Gebski, Val;
    • Jaworski, Anthony
    Publication type:
    Article
    35
    36
    37
    38
    39

    Pharmacogenetic analysis of adjuvant FOLFOX for Korean patients with colon cancer.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 843, doi. 10.1007/s00280-013-2075-3
    By:
    • Lee, Kyung-Hun;
    • Chang, Hye;
    • Han, Sae-Won;
    • Oh, Do-Youn;
    • Im, Seock-Ah;
    • Bang, Yung-Jue;
    • Kim, Sun;
    • Lee, Keun-Wook;
    • Kim, Jee;
    • Hong, Yong;
    • Kim, Tae;
    • Park, Young;
    • Kang, Won;
    • Shin, Sang;
    • Ahn, Joong;
    • Kang, Gyeong;
    • Jeong, Seung-Yong;
    • Park, Kyu;
    • Park, Jae-Gahb;
    • Kim, Tae-You
    Publication type:
    Article
    40

    Prognostic value of p21-activated kinase 4 in resected pancreatic cancer.

    Published in:
    APMIS, 2017, v. 125, n. 8, p. 699, doi. 10.1111/apm.12705
    By:
    • Park, Sehhoon;
    • Kim, Jin Won;
    • Kim, Haeryoung;
    • Kim, Ji‐Won;
    • Kim, Yu Jung;
    • Lee, Keun‐Wook;
    • Kim, Jee Hyun;
    • Kim, Jai Hwan;
    • Hwang, Jin‐Hyeok;
    • Choi, Young Rok;
    • Cho, Jai Young;
    • Yoon, Yoo‐Seok;
    • Han, Ho‐Seong
    Publication type:
    Article
    41
    42
    43

    Data collection framework for electronic medical record-based real-world data to evaluate the effectiveness and safety of cancer drugs: a nationwide real-world study of the Korean Cancer Study Group.

    Published in:
    Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221132628
    By:
    • Han, Hye Sook;
    • Lee, Kyoung Eun;
    • Suh, Young Ju;
    • Jee, Hee-Jung;
    • Kim, Bum Jun;
    • Kim, Hyeong Su;
    • Lee, Keun-Wook;
    • Ryu, Min-Hee;
    • Baek, Sun Kyung;
    • Park, In Hae;
    • Ahn, Hee Kyung;
    • Jeong, Jae Ho;
    • Kim, Min Hwan;
    • Lee, Dae Hyung;
    • Kim, Siheon;
    • Moon, Hyemi;
    • Son, Serim;
    • Byun, Ji-Hye;
    • Kim, Dong Sook;
    • An, Hyonggin
    Publication type:
    Article
    44

    Ramucirumab plus paclitaxel as second-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma: a nationwide real-world outcomes in Korea study (KCSG-ST19-16).

    Published in:
    Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211042812
    By:
    • Han, Hye Sook;
    • Kim, Bum Jun;
    • Jee, Hee-Jung;
    • Ryu, Min-Hee;
    • Park, Se Hoon;
    • Rha, Sun Young;
    • Kim, Jong Gwang;
    • Bae, Woo Kyun;
    • Lee, Keun-Wook;
    • Oh, Do-Youn;
    • Kim, In-Ho;
    • Sym, Sun Jin;
    • Oh, So Yeon;
    • Kim, Hyeong Su;
    • Byun, Ji-Hye;
    • Kim, Dong Sook;
    • Suh, Young Ju;
    • An, Hyonggin;
    • Zang, Dae Young
    Publication type:
    Article
    45

    High-Throughput Chemotherapeutic Drug Screening System for Gastric Cancer (Cure-GA).

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2025, v. 32, n. 5, p. 3781, doi. 10.1245/s10434-024-16850-0
    By:
    • Lee, Jieun;
    • Kim, In Hee;
    • Seol, Donghyeok;
    • Lee, Sangjun;
    • Yoo, Mira;
    • Lee, Tae-Kyeong;
    • Yoon, So Hee;
    • Lee, Eunju;
    • Hwang, Duyeong;
    • Kang, So Hyun;
    • Park, Young Suk;
    • Ku, Bosung;
    • Jeon, Sang Youl;
    • Choi, Yongmun;
    • Jung, Keehoon;
    • Kim, Ji-Won;
    • Kim, Jin Won;
    • Ahn, Sang-Hoon;
    • Lee, Keun-Wook;
    • Kim, Hyung-Ho
    Publication type:
    Article
    46
    47

    Safety and Efficacy of Intraperitoneal Paclitaxel Plus Intravenous Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX) for Gastric Cancer with Peritoneal Metastasis.

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 8, p. 5084, doi. 10.1245/s10434-022-11582-5
    By:
    • Kang, So Hyun;
    • Min, Sa-Hong;
    • Kim, Jin Won;
    • Lee, Eunju;
    • Park, Sang Woo;
    • Lee, Sangjun;
    • Oh, Hyeon Jeong;
    • Park, Young Suk;
    • Lee, Yoon Jin;
    • Kim, Ji-Won;
    • Ahn, Sang-Hoon;
    • Suh, Yun-Suhk;
    • Lee, Keun-Wook;
    • Lee, Hye Seung;
    • Kim, Hyung-Ho
    Publication type:
    Article
    48
    49

    Protective effect of GK2 fused BLVRA protein against oxidative stress‐induced dopaminergic neuronal cell damage.

    Published in:
    FEBS Journal, 2023, v. 290, n. 11, p. 2923, doi. 10.1111/febs.16721
    By:
    • Choi, Yeon Joo;
    • Kwon, Hyun Jung;
    • Shin, Min Jea;
    • Kim, Dae Won;
    • Youn, Gi Soo;
    • Park, Jung Hwan;
    • Yeo, Hyeon Ji;
    • Yeo, Eun Ji;
    • Kim, Hyeong Seop;
    • Lee, Lee Re;
    • Kim, Na Yeon;
    • Kwon, Su Yeon;
    • Kim, Duk‐Soo;
    • Kim, Gun Woo;
    • Park, Jinseu;
    • Han, Kyu Hyung;
    • Lee, Keun Wook;
    • Park, Jong Kook;
    • Lee, Chan Hee;
    • Eum, Won Sik
    Publication type:
    Article
    50